Antiplatelet agents in Diabetics
2016 ADA Guideline Recommendations |
Types of Diabetes Mellitus |
---|
2016 ADA Standard of Medical Care Guideline Recommendations |
Cardiovascular Disease and Risk Management |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]; Seyedmahdi Pahlavani, M.D. [3]; Tarek Nafee, M.D. [4]
2016 ADA Standards of Medical Care in Diabetes Guidelines
"1.In adults not taking statins, it is reasonable to obtain a lipid profile at the time of diabetes diagnosis, at an initial medical evaluation, and every 5 years thereafter, or more frequently if indicated. (Level of Evidence: E)" |
"2. Obtain a lipid profile at initiation of statin therapy and periodically thereafter as it may help to mon- itor the response to therapy and inform adherence. (Level of Evidence: E)" |
"3.Lifestyle modification focusing on weight loss (if indicated); the reduc- tion of saturated fat, trans fat, and cholesterol intake; increase of omega-3 fatty acids, viscous fiber, and plant stanols/sterols intake; and increased physical activity should be recommended to improve the lipid profile in patients with diabetes. (Level of Evidence: A)" |
"4.Intensify lifestyle therapy and opti- mize glycemic control for patients with elevated triglyceride levels ($150 mg/dL [1.7 mmol/L]) and/or low HDL cholesterol (,40 mg/dL [1.0 mmol/L] for men, ,50 mg/dL [1.3 mmol/L] for women. (Level of Evidence: C)" |
"5.For patients with fasting triglyceride levels $500 mg/dL (5.7 mmol/L), evaluate for secondary causes of hypertriglyceridemia and consider medical therapy to reduce the risk of pancreatitis. (Level of Evidence: C)" |
"6.For patients of all ages with diabetes and atherosclerotic cardiovascular dis- ease, high-intensity statin therapy should be added to lifestyle therapy. (Level of Evidence: A)" |